AACR 2018: A patient-researcher collaboration targeting ROS1 cancer

Source: E Cancer News, May 2018

Cancer patients have often organized support and informational groups around their disease types.
Now a presentation at the American Association for Cancer Research (AACR) Annual Meeting 2018 describes the first research-focused group of patients organized around the genetic mutation that creates their cancer, namely changes to the gene ROS1.
While “ROS1 fusion" has primarily been studied in lung cancer, the Global ROS1 Initiative includes ROS1-positive (ROS1 ) patients with melanoma and pancreatic cancer as well.